Skip to main content

Meeting the Healthcare Needs of Canadians

+1 (800) 737-3928

Category: Trimedic News

  • First novel beta-blocker in over 20 years

    First novel beta-blocker in over 20 years

    Novel beta-blocker Announcement Development and clinical data from the European Healthcare company AOP Orphan Pharmaceuticals AG form the basis of introducing the new drug Landiolol in Canada for rapid heart rate control in the hospital setting. Trimedic Therapeutics Inc will immediately become the Canadian market authorization holder and exclusive distributor.